Artificial intelligence is helping researchers fill in critical gaps in medical treatment by identifying new drug targets for more precision medicine solutions.
Advances in data integration enable scientists to combine multiomics data and a patient’s clinical record to develop precision medicine approaches for treating disease.
A herpes virus peptide binds and sequesters proteins important for MYC activation in lymphoma cells, presenting a new viral strategy for treating undruggable MYC-dependent cancers.